Sign In
Buy CCXI
$10.24
+0.0150 (+0.147%)
At Close: Jun 03, 2026
J.P. Morgan Sticks to Its Buy Rating for ChemoCentryx (CCXI)
06:07pm, Wednesday, 11'th Mar 2020
In a report released today, Anupam Rama from J.P. Morgan maintained a Buy rating on ChemoCentryx (CCXI – Research Report),
ChemoCentryx price target raised to $64 from $56 at Raymond James CCXI
11:41am, Wednesday, 11'th Mar 2020
ChemoCentryx price target raised to $64 from $56 at Raymond James Raymond James CCXI
Analysts Offer Insights on Healthcare Companies: ChemoCentryx (CCXI), Crinetics Pharmaceuticals (CRNX) and Trillium Therapeutics (TRIL)
11:14am, Wednesday, 11'th Mar 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ChemoCentryx (CCXI), Crinetics Pharmaceuticals (CRNX) and
